RT Book, Section
A1 Ruiz-Negrón, Natalia
A1 Blumenthal, Donald K.
A2 Brunton, Laurence L.
A2 Knollmann, Björn C.
SR Print(0)
ID 1202431404
T1 Drug Therapy for Dyslipidemias
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264258079
LK accessmedicine.mhmedical.com/content.aspx?aid=1202431404
RD 2024/04/19
AB Dyslipidemia  is  a  disorder  of  lipoprotein  metabolism,  including  lipoprotein  overproduction  or  deficiency.  Dyslipidemia  is  a  major  cause  of  atherosclerotic  cardiovascular  disease  (ASCVD),  ischemic  cerebrovascular  disease,  and  peripheral  vascular  disease.  Cardiovascular  disease  is  the  number  one  cause  of  death  globally  (World  Health  Organization,  2020).  Genetic  disorders,  metabolic  diseases  such  as  diabetes  mellitus,  and  lifestyle  factors  are  common  causes  of  dyslipidemias,  including  hypercholesterolemia  and  low  levels  of  high-density  lipoprotein  (HDL)  cholesterol.